Pharmacodynamics of doxycycline

[1] BUNDTZEN RW, 1981, REV INFECT DIS, V3, P28

[2] THE POSTANTIBIOTIC SUB-MIC EFFECT INVITRO AND INVIVO [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 : 159 - 166

[3] INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) : 89 - 96

[4] Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) : 1 - 10

[5] Craig WA, 1996, ANTIBIOTICS LAB MED, P296

[6] Cunha BA, 1997, ADV THER, V14, P172

[7] Cunha BA, 1997, DRUGS TODAY, V33, P213

[8] THE TETRACYCLINES [J]. MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (01) : 293 - 302

[9] CUNHA BA, 1985, TETRACYCLINES, P393

[10] CUNHA BA, 1979, POSTGRAD MED COMM, V1, P43

[1] BUNDTZEN RW, 1981, REV INFECT DIS, V3, P28

[2] THE POSTANTIBIOTIC SUB-MIC EFFECT INVITRO AND INVIVO [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 : 159 - 166

[3] INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) : 89 - 96

[4] Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men [J]. CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) : 1 - 10

[5] Craig WA, 1996, ANTIBIOTICS LAB MED, P296

[6] Cunha BA, 1997, ADV THER, V14, P172

[7] Cunha BA, 1997, DRUGS TODAY, V33, P213

[8] THE TETRACYCLINES [J]. MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (01) : 293 - 302

[9] CUNHA BA, 1985, TETRACYCLINES, P393

[10] CUNHA BA, 1979, POSTGRAD MED COMM, V1, P43